Huawei Unveils Logic Folding Chip Approach as Rivalry With Nvidia and Apple Intensifies OpenAI Reportedly Prepares Confidential IPO Filing Signaling AI Market Leadership SEBI Digital Bonds Plan May Deepen Indias Debt Market Spotify Eyes AIPowered Remix Features to Drive Premium Subscriber Growth SpaceXs Nasdaq IPO Prospects Hinge on Starlink as Key Growth Driver Prospectus Shows Spencer Pratts Online Campaign Strategy A Case Study in Digital Political Marketing and Its Potential Market Implications PAM Q1 2026 Earnings Stellar Earnings Beat Driven by Exceptional Operational Performance Contango ORE Inc CTGO Q1 2026 Earnings Significant EPS Miss Weighs on Shares TIMB Q1 2026 Earnings EPS Misses Estimates by 1156 Despite Modest Stock Uptick Hour Loop Inc HOUR Q4 2024 Earnings Narrowing Loss Amid Quiet Quarter USBC Q1 2025 Earnings Narrowing Loss Exceeds Expectations New Found Gold Corp NFGC Q1 2026 Earnings EPS Miss Highlights Exploration Stage Challenges Moelis Company MC Holds Steady Near Support Amid Modest Gains American International Group AIG Stock Declines 249 Testing Key Support Levels Virtus Global MultiSector Income Fund VGI Edges Higher Yield Support Remains Intact PIMCO Dynamic Income Opportunities Fund PDO Advances 156 as Yield Appeal Drives Buying Interest Sequans Communications SQNS Gains 37 as Shares Test Key Resistance Wingstop Shares Slide 12 as Quarterly Profit Misses Analysts Expectations SANA Q1 2026 Earnings Narrower Loss Per Share Surprises on Operational Progress SEACOR Marine Holdings SMHI Slides 11 as Shares Approach Key Support Zone Phibro Animal Health PAHC Holds Steady Near Support as Bulls Eye Resistance HIVE Digital Technologies HIVE Edges Higher by 157 as Crypto Mining Sentiment Improves CrowdStrike CRWD Surges 456 as Cybersecurity Demand Drives Momentum FIGX Capital Acquisition Corp FIGX Holds Steady at 1022 A Stalemate Between Support and Resistance News Corporation NWS Edges Lower as Resistance Holds Firm Brera Holdings SLMT Climbs 397 as Bulls Test Key Resistance Near 674 Akebia Therapeutics AKBA Edges Higher at 104 Key Levels in Focus